The effect of continuous positive airway pressure usage on sleepiness in obstructive sleep apnoea: Real effects or expectation of benefit?

Thorax

Volumn 67, Issue 10, 2012, Pages 920-924

  Crawford, Megan R ^a,b   Bartlett, Delwyn J ^a   Coughlin, Steven R ^c   Phillips, Craig L ^a,d   Neill, Alister M ^e   Espie, Colin A ^a,b   Dungan II, George C ^a   Wilding, John P H ^c   Calverley, Peter M A ^c   Grunstein, Ronald R ^a,f   Marshall, Nathaniel S ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

^d ROYAL NORTH SHORE HOSPITAL   (Australia)

^e UNIVERSITY OF OTAGO   (New Zealand)

^f ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; APNEA HYPOPNEA INDEX; ARTICLE; BODY MASS; CONTROLLED STUDY; CROSSOVER PROCEDURE; DAYTIME SOMNOLENCE; DOSE RESPONSE; EPWORTH SLEEPINESS SCALE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; PSYCHOBIOLOGY; SLEEP APNEA SYNDROME; SOMNOLENCE;

EID: 84866133654     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2012-201622     Document Type: Article

References (25)

1. Choudhry NK, Fischer MA, Avorn J, et al . The implications of therapeutic complexity on adherence to cardiovascular medications. Arch Intern Med 2011; 171:814-22.
2. Osterberg L, Blaschke T. Adherence to medication. N Eng J Med 2005;353:487-97. (Pubitemid 41127293)
3. Finniss DG, Kaptchuk TJ, Miller F, et al. Biological, clinical, and ethical advances of placebo effects. Lancet 2010;375:686-95.
4. Kirsch I. Response expectancy as a determinant of experience and behavior. Am Psychol 1985;40:1189-202.
5. Kingshott RN, Vennelle M, Hoy CJ, et al. Predictors of improvements in daytime function outcomes with CPAP therapy. Am J Respir Crit Care Med 2000;161:866-71. (Pubitemid 30171744)
6. Weaver TE, Maislin G, Dinges DF, et al. Relationship between hours of CPAP use and achieving normal levels of sleepiness and daily functioning. Sleep 2007;30:711-19. (Pubitemid 46854758)
7. Antic NA, Catcheside P, Buchan C, et al. The effect of CPAP in normalizing daytime sleepiness, quality of life, and neurocognitive function in patients with moderate to severe OSA. Sleep 2011;34:111-19.
8. Stepnowsky CJ, Dimsdale JE. Dose-response relationship between CPAP compliance and measures of sleep apnea severity. Sleep Med 2002;3:329-34.
9. Marshall NS, Neill AM, Campbell AJ, et al. Randomised controlled crossover trial of humidified continuous positive airway pressure in mild obstructive sleep apnoea. Thorax 2005;60:427-32. (Pubitemid 40685827)
10. Phillips CL, Yee BJ, Marshall NS, et al. Continuous positive airway pressure reduces post prandial lipidemia in obstructive sleep apnea. A randomised, placebo controlled crossover trial. Am J Respir Crit Care Med 2011; 184:355-61.
11. Coughlin SR, Mawdsley L, Mugarza JA, et al. Cardiovascular and metabolic effects of CPAP in obese males with OSA. Eur Respir J 2007;29:720-7. (Pubitemid 46554622)
12. Johns MW. A new method for measuring daytime sleepiness - the Epworth Sleepiness Scale. Sleep 1991;14:540-5.
13. Kazis L, Anderson J, Meenan R. Effect sizes for interpreting changes in health status. Med Care 1989; 27:S178-89.
14. Engleman HM, Kingshott RN, Wraith PK, et al. Randomized placebo-controlled crossover trial of continuous positive airway pressure for mild sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med 1999;159:461-7. (Pubitemid 29084866)
15. Stradling JR, Davies RJO. Is more NCPAP better? Sleep 2000; 23:S150-3. (Pubitemid 30462674)
16. Weaver TE, Grunstein RR. Adherence to continuous positive airway pressure therapy: the challenge to effective treatment. Proc Am Thorac Soc 2008;5:173-8. (Pubitemid 351237875)
17. Karlawish JH, Pack AI. Addressing the ethical problems of randomized and placebo-controlled trials of CPAP. Am J Respir Crit Care Med 2001;163:809-10. (Pubitemid 32275843)
18. Platt AB, Kuna ST. To adhere or not to adhere - patients selectively decide. Sleep 2009;32:583-4.
19. Platt AB, Kuna ST, Field SH, et al. Adherence to sleep apnea therapy and use of lipid-lowering drugs. Chest 2010;137:102-8.
20. Villar I, Izuel M, Carrizo S, et al. Medication adherence and persistence in severe obstructive sleep apnea. Sleep 2009;32:623-8.
21. Richards D, Bartlett DJ, Wong K, et al. Increased adherence to CPAP with a group cognitive behavioral treatment intervention: a randomized trial. Sleep 2007;30:635-40. (Pubitemid 46941569)
22. Modi AC, Rausch JR, Glauser TA. Patterns of nonadherence to antiepileptic drug therapy in children with newly diagnosed epilepsy. JAMA 2011;305:1669-76.
23. Aloia MS, Goodwin MS, Velicer WF, et al. Time series analysis of treatment adherence patterns in individuals with obstructive sleep apnea. Ann Behav Med 2008;36:44-53.
24. Smith I, Lasserson TJ. Pressure modification for improving usage of continuous positive airway pressure machines in adults with obstructive sleep apnoea. Cochrane Database Syst Rev 2009;(4):CD003531.
25. Bakker JP, Marshall NS. Flexible pressure delivery modification of continuous positive airway pressure for obstructive sleep apnea does not improve compliance with therapy: systematic review and meta-analysis. Chest 2011;139:1322-30.